Zynerba CEO talks through clinical updates for its lead indications and plans for 2022



Zynerba Pharmaceuticals Inc CEO Armando Anido talks to Proactive about program updates for Fragile X syndrome, autism …

Be the first to comment

Leave a Reply

Your email address will not be published.


*